Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16205940rdf:typepubmed:Citationlld:pubmed
pubmed-article:16205940lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C0238790lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C0003865lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C2828366lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C1705851lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C1555707lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C0054433lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C2752151lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C0600686lld:lifeskim
pubmed-article:16205940lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:16205940pubmed:issue3lld:pubmed
pubmed-article:16205940pubmed:dateCreated2006-2-10lld:pubmed
pubmed-article:16205940pubmed:abstractTextSimon extracts are vitamin K(1)-rich food materials extracted from the leaves of the Simon sweet potato. Although vitamin K is known to stimulate bone formation, we postulated that Simon extracts also contain unknown biological compounds having the ability to regulate bone resorption. Here we prepared the vitamin K-free fraction from the Simon extracts and investigated the ability of this fraction on the differentiation of osteoclasts. A remarkable inhibitory effect of osteoclastogenesis was observed when osteoclast precursors were treated with this fraction in rat bone marrow culture systems as well as in a pure differentiation system using murine osteoclast precursor cell line. The vitamin K-free Simon extracts markedly suppressed severe bone destruction mediated by abundant osteoclasts associated with adjuvant-induced arthritis in rats. High performance liquid chromatography (HPLC) analysis revealed that the vitamin K-free Simon extracts contained three types of low molecular weight inhibitors for osteoclastogenesis; caffeic acid, chlorogenic acids and isochlorogenic acids. Among these substances, caffeic acid showed the most powerful inhibitory effects on osteoclastogenesis. Caffeic acid significantly suppressed expression of NFATc1, a key transcription factor for the induction of osteoclastogenesis. Our current study enlightened a high utility of the Simon extracts and their chemical components as effective regulators for bone resorption accompanied with inflammation and metabolic bone diseases.lld:pubmed
pubmed-article:16205940pubmed:languageenglld:pubmed
pubmed-article:16205940pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:citationSubsetIMlld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16205940pubmed:statusMEDLINElld:pubmed
pubmed-article:16205940pubmed:monthMarlld:pubmed
pubmed-article:16205940pubmed:issn0948-6143lld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:SandraFerryFlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:IijimaTadahik...lld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:ZhouWuWlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:NagataKengoKlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:KukitaAkikoAlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:KukitaToshioTlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:KumagiMidoriMlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:TohKazukoKlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:TangQuan...lld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:RasubalaLinda...lld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:UshijimaYukiYlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:OkumaYutakaYlld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:KawasakiSadam...lld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:TeramachiJunp...lld:pubmed
pubmed-article:16205940pubmed:authorpubmed-author:MiyamotoIchik...lld:pubmed
pubmed-article:16205940pubmed:issnTypePrintlld:pubmed
pubmed-article:16205940pubmed:volume125lld:pubmed
pubmed-article:16205940pubmed:ownerNLMlld:pubmed
pubmed-article:16205940pubmed:authorsCompleteYlld:pubmed
pubmed-article:16205940pubmed:pagination215-25lld:pubmed
pubmed-article:16205940pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:meshHeadingpubmed-meshheading:16205940...lld:pubmed
pubmed-article:16205940pubmed:year2006lld:pubmed
pubmed-article:16205940pubmed:articleTitleRegulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats.lld:pubmed
pubmed-article:16205940pubmed:affiliationOral Cellular and Molecular Biology, Kyushu University, Maidashi 3-1-1, Fukuoka, 812-8582, Japan.lld:pubmed
pubmed-article:16205940pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16205940pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:16205940pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed